Emotional experience and D2 receptor occupancy in patients with schizophrenia treated with antipsychotics

被引：0
|
作者：
Lataster, J. [1 ]
van Os, J. [2 ]
de Haan, L. [3 ]
Thewissen, V. [1 ]
Bak, M. [2 ]
Lataster, T. [2 ]
Lardinois, M. [2 ]
Delespaul, P. A. [2 ]
Myin-Germeys, I. [2 ]
机构：
[1] Open Univ, Fac Psychol, Heerlen, Netherlands
[2] Maastricht Univ, Dept Psychiat & Psychol, Maastricht, Netherlands
[3] Univ Amsterdam, Acad Med Ctr, Dept Psychiat, NL-1105 AZ Amsterdam, Netherlands
来源：
PSYCHOLOGY & HEALTH | 2012年 / 27卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
引用
收藏
页码：77 / 77
页数：1
相关论文
共 50 条
  • [21] Long-term stability of measuring D2 receptors in schizophrenia patients treated with antipsychotics
    Uchida, Hiroyuki
    Graff-Guerrero, Ariel
    Mulsant, Benoit H.
    Pollock, Bruce G.
    Mamo, David C.
    SCHIZOPHRENIA RESEARCH, 2009, 109 (1-3) : 130 - 133
  • [22] Estimated dopamine D2 receptor occupancy from plasma concentrations of atypical antipsychotics and subjective experience/drug attitude in schizophrenia: An analysis of the CATIE data
    Takeuchi, Hiroyoshi
    Suzuki, Takefumi
    Bies, Robert R.
    Remington, Gary
    Mamo, David C.
    Pollock, Bruce G.
    Mimura, Masaru
    Uchida, Hiroyuki
    SCHIZOPHRENIA RESEARCH, 2013, 150 (2-3) : 373 - 379
  • [23] In vivo determination of striatal dopamine D2 receptor occupancy in patients treated with olanzapine
    Raedler, TJ
    Knable, MB
    Lafargue, T
    Urbina, RA
    Egan, MF
    Pickar, D
    Weinberger, DR
    PSYCHIATRY RESEARCH-NEUROIMAGING, 1999, 90 (02) : 81 - 90
  • [24] The Optimal Dopamine D2 Receptor Occupancy by Antipsychotics in Patients with Late-Life Schizophrenia: A [11C]-Raclopride PET Study
    Nakajima, Shinichiro
    Mamo, David
    Uchida, Hiroyuki
    Suzuki, Takefumi
    Rajji, Tarek
    Caravaggio, Fernando
    Gerretsen, Philip
    Mimura, Masaru
    Mulsant, Benoit
    Pollock, Bruce
    Graff-Guerrero, Ariel
    BIOLOGICAL PSYCHIATRY, 2014, 75 (09) : 105S - 105S
  • [25] Hyperprolactinemia and estimated dopamine D2 receptor occupancy in patients with schizophrenia: Analysis of the CATIE data
    Tsuboi, Takashi
    Bies, Robert R.
    Suzuki, Takefumi
    Mamo, David C.
    Pollock, Bruce G.
    Graff-Guerrero, Ariel
    Mimura, Masaru
    Uchida, Hiroyuki
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2013, 45 : 178 - 182
  • [26] Comfort, self-confidence, safety, and dopamine D2 receptor occupancy by antipsychotics
    De Haan, L
    Lavalaye, J
    Booij, J
    Linzen, D
    AMERICAN JOURNAL OF PSYCHIATRY, 2005, 162 (08): : 1544 - 1545
  • [27] META-ANALYSIS OF D2 RECEPTOR OCCUPANCY-PLASMA CONCENTRATION FOR ANTIPSYCHOTICS
    Ahadieh, S.
    Corrigan, B.
    Riley, S.
    Lalonde, R.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2009, 85 : S64 - S64
  • [28] Typical and atypical antipsychotics:: Affinity and occupancy at the striatal dopamine D2 receptor and transporter
    Schmitt, GJE
    Meisenzahl, EM
    Frodl, T
    Dresel, S
    la Fougère, C
    Hahn, K
    Möller, HJ
    EUROPEAN PSYCHIATRY, 2004, 19 : 70S - 70S
  • [29] Pharmacokinetics and time-course of D2 receptor occupancy induced by atypical antipsychotics in stabilized schizophrenic patients
    Catafau, A. M.
    Penengo, M. M.
    Nucci, G.
    Bullich, S.
    Corripio, I.
    Parellada, E.
    Garcia-Ribera, C.
    Gomeni, R.
    Merlo-Pich, E.
    JOURNAL OF PSYCHOPHARMACOLOGY, 2008, 22 (08) : 882 - 894
  • [30] D2 receptor occupancy in risperidone and clozapine-treated schizophrenics
    Su, TP
    Breier, A
    Coppola, R
    Hadd, K
    Elman, I
    Adler, C
    Malhotra, AK
    Watsky, E
    Gorey, J
    Weinberger, D
    Pickar, D
    BIOLOGICAL PSYCHIATRY, 1996, 39 (07) : 51 - 51
12345